Expertise in
23
conditions

Dr. Gregory Wiener

Gastroenterology
Gregory J. Wiener M D Professional Corp.
353 Church Ave # A, 
Chula Vista, CA 
Expertise in
23
conditions
Gregory J. Wiener M D Professional Corp.
353 Church Ave # A, 
Chula Vista, CA 

Overview

Gregory Wiener is a Gastroenterologist in Chula Vista, California. Dr. Wiener is highly rated in 23 conditions, according to our data. His top areas of expertise are Gastroparesis, Non-Alcoholic Fatty Liver Disease, Gastroesophageal Reflux Disease (GERD), Visceromegaly, and Endoscopy.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Gastroenterology

Licenses

Internal Medicine in CA

Hospital Affiliations

Scripps Mercy Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health Group
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Gregory J. Wiener M D Professional Corp.
353 Church Ave # A, Chula Vista, CA 91910
Other Locations
Scripps Mercy Hospital Chula Vista
435 H St, Chula Vista, CA 91910

Additional Areas of Focus

Dr. Wiener has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Procedure, Diagnostic test
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
Enrollment Status: Completed
Publish Date: September 16, 2020
Intervention Type: Drug
Study Phase: Phase 2
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold
Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold
Enrollment Status: Completed
Publish Date: July 21, 2020
A Randomized, Placebo-controlled, Double-blinded, Multicenter Study of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo, in Adult Subjects With Chronic Idiopathic Constipation
A Randomized, Placebo-controlled, Double-blinded, Multicenter Study of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo, in Adult Subjects With Chronic Idiopathic Constipation
Enrollment Status: Completed
Publish Date: January 14, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis
Enrollment Status: Completed
Publish Date: April 17, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 8 Less Clinical Trials

5 Total Publications

A Phase 2 evaluation of a new flavored peg and sulfate solution compared to an over-the-counter laxative, peg and sports drink bowel preparation combination.
A Phase 2 evaluation of a new flavored peg and sulfate solution compared to an over-the-counter laxative, peg and sports drink bowel preparation combination.
Journal: BMC gastroenterology
Published: July 16, 2023
Similar Doctors
William Sandborn
Expertise in
15
conditions
Dr. William Sandborn
Gastroenterology
Expertise in
15
conditions
Dr. William Sandborn
Gastroenterology

Office

9350 Campus Point Dr Ste 2B, 
La Jolla, CA 
 (18.0 miles away)
619-543-2347
Languages Spoken:
English
See accepted insurances

William Sandborn is a Gastroenterologist in La Jolla, California. Dr. Sandborn is highly rated in 15 conditions, according to our data. His top areas of expertise are Crohn's Disease, Hemorrhagic Proctocolitis, Ulcerative Colitis, Endoscopy, and Colonoscopy.

Expertise in
13
conditions
Dr. Rena Yadlapati
Gastroenterology
Expertise in
13
conditions
Dr. Rena Yadlapati
Gastroenterology

UC San Diego Health Clinical Laboratory-La Jolla

9350 Campus Point Dr, 
La Jolla, CA 
 (18.6 miles away)
619-543-2347
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rena Yadlapati is a Gastroenterologist in La Jolla, California. Dr. Yadlapati is highly rated in 13 conditions, according to our data. Her top areas of expertise are Gastroesophageal Reflux Disease (GERD), Achalasia, Heartburn, Endoscopy, and Colonoscopy.

Brigid Boland
Expertise in
9
conditions
Dr. Brigid Boland
Gastroenterology
Expertise in
9
conditions
Dr. Brigid Boland
Gastroenterology

UC San Diego Student Health SVC Pharmacy

9500 Gilman Dr, 
La Jolla, CA 
 (18.7 miles away)
858-534-3300
Experience:
18+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Brigid Boland is a Gastroenterologist in La Jolla, California. Dr. Boland has been practicing medicine for over 18 years is highly rated in 9 conditions, according to our data. Her top areas of expertise are Ulcerative Colitis, Crohn's Disease, Hemorrhagic Proctocolitis, Colonoscopy, and Endoscopy.

Frequently Asked Questions about Dr. Gregory Wiener

How do I make an appointment with Dr. Gregory Wiener?

You can book an appointment with Dr. Gregory Wiener by calling their office at 619-585-8883. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Gregory Wiener a top-rated expert for Gastroparesis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gregory Wiener is classified as an Distinguished expert for Gastroparesis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gregory Wiener specialize in?

While Dr. Gregory Wiener is a Gastroenterology, they have specific expertise in Gastroparesis, Non-Alcoholic Fatty Liver Disease, and Gastroesophageal Reflux Disease (GERD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Gregory Wiener participate in research or clinical trials?

Yes. Dr. Gregory Wiener has published 5 articles and abstracts on conditions like Gastroparesis. You can view a list of Dr. Gregory Wiener's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Gregory Wiener accept my insurance?

Dr. Gregory Wiener accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 619-585-8883 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wiener's expertise for a condition
ConditionClose
    View All 20 Advanced Conditions
    View All 44 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile